Latest News and Press Releases

Information on the total number of voting rights (denominator) Liège, Belgium, 27 June 2017 [5:45 pm CET] - Regulated information - In accordance with article 15 of the Act of 2 May 2007 on the...

PRESS RELEASE Estelle® Phase IIb results on well-being and BODY weight published in LEADING peer-reviewed journal European Journal Of Contraception and Reproductive Health Care publishes article...

NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS...

NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS...

PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR ADDITIONAL estelle® SAFETY studY Safety study is part of the development of Estelle®, Mithra's combined oral contraceptive candidate Aim of the...

PRESS RELEASE Mithra RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY               Orphan Drug Designation received from European Medicines Agency for Estetrol...

PRESS RELEASE Mithra signs Exclusive agreement for Tibelia® in Canada               Tibelia® would be the first tibolone-based Hormone Therapy product available in Canada Marketing...

PRESS RELEASE Mithra obtains marketing authoriZation for Tibelia® in France French MA completes decentralized procedure with MAs granted in 15 European countries Tibelia® is currently...

mithra receives gmp approval for myring(TM) production On track to file for marketing approval of hormonal contraceptive MyringTM in EU and US in Q2 2017 Approval ensures Mithra fully...

PRESS RELEASE Mithra AND Gynial SIGN COMMERCIALIZATION AGREEMENT FOR MyringTM in Austria               Mithra grants non-exclusive 10-year license for vaginal contraception ring MyringTM to...